Details of the Drug Reposition

General Information of This Drug (ID: DM0GXWT)

Drug Name
ABP 654   DM0GXWT
Synonyms Ustekinumab biosimilar
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Plaque psoriasis DISQX1LF EA90.0 Phase 3 [1]
Psoriatic arthritis DISLWTG2 FA21 Phase 3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04607980) A Phase 3, Multicenter, Randomized, Double-Blind Study Evaluating the Efficacy and Safety of ABP 654 Compared With Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis. U.S.National Institutes of Health.